Keywords: زنده ماندن بدون عود; Breast cancer; Certified breast cancer centres; Quality assurance; Benchmarking; Guideline adherence; Relapse-free survival; Overall survival;
مقالات ISI زنده ماندن بدون عود (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: زنده ماندن بدون عود; APC; antigen presenting cell; APOBEC; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like; BRCA1/2; breast cancer 1/2; BCSS; breast cancer specific survival; B2M; β-2-microglobulin; CAF; cancer associated fibroblast; CCL; chemokine ligand; CD
Keywords: زنده ماندن بدون عود; Colorectal Cancer; Microsatellite Instability; Tumorigenic Process; Driver Gene Mutations; Positive and Negative Selection; bp; base pair; CRC; colorectal cancer; HR; hazard ratio; indel; insertion/deletion; MLH1; MutL Homolog 1; MMR; mismatch repair; mRN
Keywords: زنده ماندن بدون عود; AML; acute myeloid leukemia; BSC; best supportive care; CI; confidence interval; CIR; cumulative incidence of relapse; CR; complete remission; CRc; composite CR (includes CR, CRi, and CRp); CRi; CR with incomplete hematologic recovery; CRMRDâ; CR with a
Keywords: زنده ماندن بدون عود; carcinoma; transitional cell; recurrence; prognosis; nomograms; CHAID; chi-square automatic interaction detection; CIS; carcinoma in situ; F1; F measure; LND; lymphadenectomy; LOOCV; leave-one-out cross-validation; LVI; lymphovascular invasion; RFS; relap
Keywords: زنده ماندن بدون عود; BCL-2; B-cell lymphoma 2; CA-125; cancer antigen-125; CAFs; cancer-associated fibroblasts; CCL17; chemokine (C-C motif) ligand 17; CCL2; chemokine (C-C motif) ligand 2; CXCL12; chemokine (C-X-C motif) ligand 12; DFS; disease-free survival; DNMT; DNA methy
Keywords: زنده ماندن بدون عود; Acute myeloid leukemia; Antecedent myelodysplastic syndrome; Overall survival; Relapse-free survival; Therapy-related;
Keywords: زنده ماندن بدون عود; AE; adverse event; ALL; acute lymphoblastic leukemia; alloSCT; allogeneic hematopoietic stem cell transplant; AYA; adolescent and young adult; BFM; Berlin-Frankfurt-Münster; CAR-T; chimeric antigen receptor-modified T cell; CCyR; complete cytogenetic r
Keywords: زنده ماندن بدون عود; 13; 28; CT; computed tomography; MG; myasthenia gravis; MRI; magnetic resonance imaging; OS; overall survival; PTMG; postthymectomy myasthenia gravis; PTx; partial thymectomy; RFS; relapse-free survival; TTx; total thymectomy; VATS; video-assisted thoraco
Keywords: زنده ماندن بدون عود; Breast cancer; Liver metastasis; Claudin-2; Prognostic biomarker; BCSS; breast cancer specific survival; CI; confidence interval; CLDN2; claudin-2 mRNA; ER; estrogen receptor; HR; hazard ratio; IHC; immunohistochemistry; LiMFS; liver metastasis-free survi
Long noncoding RNA CYTOR in cancer: A TCGA data review
Keywords: زنده ماندن بدون عود; Long non-coding RNA; CYTOR; Cancer; Prognosis; Meta-analysis; ceRNA; Competing endogenous RNA; COAD; Colon adenocarcinoma; DFS; Disease-free survival; EMT; Epithelial to mesenchymal transition; ESCA; Oesophageal carcinoma; HR; Hazard ratio; KICH; Kidney C
Proteins of the retinoblastoma pathway, FEN1 and MGMT are novel potential prognostic biomarkers in pancreatic adenocarcinoma
Keywords: زنده ماندن بدون عود; Rb; retinoblastoma-associated protein-1; CDK4/6; cyclin-dependent kinases 4 and 6; MGMT; O6-methylguanine-DNA-alkyltranferase; FEN1; flap endonuclease-1; PDAC; pancreatic ductal adenocarcinoma; DFS; disease-free survival; RFS; relapse-free survival; OS; o
Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells
Keywords: زنده ماندن بدون عود; ER; estrogen receptor; miRNAs; microRNAs; QRT-PCR; quantitative real-time polymerase chain reaction; Ct; threshold cycle; DEGs; differentially expressed genes; DEMs; differentially expressed miRNAs; PPI; protein-protein interaction; GEO; Gene Expression O
Long noncoding RNA LINC00152 as a novel predictor of lymph node metastasis and survival in human cancer: a systematic review and meta-analysis
Keywords: زنده ماندن بدون عود; OS; overall survival; RFS; relapse-free survival; DFS; disease-free survival; PFS; progression-free survival; OR; odds ratios; HR; hazard ratio; CI; 95% confidence interval; LNM; lymph node metastasis; DM; distant metastasis; NOS; Newcastle-Ottawa Scale;
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
Keywords: زنده ماندن بدون عود; BC; breast Cancer; ER; estrogen Receptor; PgR,PR; progesteron receptor; HER-2; human epidermal growth factor receptor 2; TNBC; triple negative breast cancer; ncRNA; non coding RNA; CpG(s); cytosine-phosphate-guanine dinucleotide(s); 5-me-C; 5-methyl-cytos
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia (ALL): The spectrum of clonal heterogeneity and its impact on prognosis
Keywords: زنده ماندن بدون عود; ETV6/RUNX1-positive ALL; Childhood leukemia; FISH; ETV6/RUNX1 fusion gene; Cytogenetics; ALL; acute lymphoblastic leukemia; EFS; event-free survival; OS; overall survival; RFS; relapse-free survival; BM; bone marrow; SUB; subclones; mSUB; minor subclones;
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation
Keywords: زنده ماندن بدون عود; Breast cancer; Ubiquitin-proteasome system; PSMD2; Cell cycle; p21; p27; BC; breast cancer; CI; confidence interval; DMFS; distant-metastasis-free survival; DUBs; deubiquitinating enzymes; E1s; Ub-activating enzymes; E2s; Ub-conjugating enzymes; E3s; Ub-p
Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic
Keywords: زنده ماندن بدون عود; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; AUC; Area under the curve; AZA; 5-azacytidine; 5-aza-CdR; 2â²-deoxy-5-azacytidine; 5-aza-CR; 5-azacytidine; AZN; Azanucleosides; BED; Biologically effective dose; BSC; Best supportive care;
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia
Keywords: زنده ماندن بدون عود; Acute lymphoblastic leukemia; T cell; Hematopoietic cell transplantation; Allogeneic; Survival; Relapse-free survival;
Original contributionOverexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up
Keywords: زنده ماندن بدون عود; TNBC; triple-negative breast cancer; IHC; immunohistochemistry; OS; overall survival; RFS; relapse-free survival; Breast cancer; PP2A; HER2; p-AKT; Ki-67;
Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments
Keywords: زنده ماندن بدون عود; lncRNAs; long non-coding RNAs; CM; cutaneous melanoma; OS; overall survival; AJCC; American Joint Committee on Cancer; RFS; relapse-free survival; EGFR; epidermal growth factor receptor; BANCR; BRAF-activated non-protein coding RNA; MAPK; mitogen-activate
Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling
Keywords: زنده ماندن بدون عود; miRNAs; microRNAs; FC; fold change; qRT-PCR; quantitative reverse transcription-polymerase chain reaction; KEGG; Kyoto Encyclopedia of Genes and Genomes; GO; Gene Ontology; FDR; false discovery rate; KM; Kaplan-Meier; OS; overall survival; DMFS; distant m
ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemia
Keywords: زنده ماندن بدون عود; B-ALL; B-cell acute lymphoblastic leukemia; ATO; arsenic trioxide; ADAMA; disintegrin and metalloproteinases; RFS; relapse-free survival; EFS; event-free survival; OS; overall survival; CR; complete remission; CNS; central nervous system; ATRA; all-trans
Research ArticleSIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma
Keywords: زنده ماندن بدون عود; HCC; hepatocellular carcinoma; RFS; relapse-free survival; OS; overall survival; mTOR; mammalian target of rapamycin; SIRT1; silent mating-type information regulation 2 homolog 1; AMPK; AMP-activated protein kinase; ROS; reactive oxygen species; ACC; acet
Patients With Colorectal Tumors With Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil-Based Chemotherapy
Keywords: زنده ماندن بدون عود; Therapeutic Response; Prognostic Factor; Outcome; Treatment; CRC; colorectal cancer; DT; deletion status; EBV; Epstein-Barr Virus; 5-FU; 5-fluorouracil; HSP; heat shock protein; MMR; mismatch repair; mRNA; messenger RNA; MSI; microsatellite instability; M
A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers
Keywords: زنده ماندن بدون عود; ZNF217; Estrogen Receptor-α; Breast cancer; Estrogen signalling; Biomarker; Endocrine therapy resistance; KLF; Krüppel-like factor; ERα; estrogen receptor alpha; ER+; ERα-positive; E2; 17β-estradiol; IP; immunoprecipitation; PLA; proximity ligation a
Day 22 of induction therapy is important for minimal residual disease assessment by flow cytometry in childhood acute lymphoblastic leukemia
Keywords: زنده ماندن بدون عود; ALL; acute lymphoblastic leukemia; MRD; minimal residual disease; FCM; flow cytometry; BM; bone marrow; LR; low risk; IR; intermediate risk; HR; high risk; EFS; event-free survival; RFS; relapse-free survival; CR; complete remission; CCR; continuous compl
Effect of Large Tumor Size on Cancer-Specific Mortality in Node-Negative Breast Cancer
Keywords: زنده ماندن بدون عود; AJCC; American Joint Committee on Cancer; BCSM; breast cancer-specific mortality; DRFS; distant relapse-free survival; ER; estrogen receptor; FDSCC; Fudan University Shanghai Cancer Center; HR; hazard ratio; LN; lymph node; NCT; neoadjuvant chemotherapy
Brachytherapy in Lip Carcinoma: Long-Term Results
Keywords: زنده ماندن بدون عود; Lip carcinoma; Low-dose-rate brachytherapy; Local control; Relapse-free survival;
Hyperglycemia during Induction Therapy is Associated with Poorer Survival in Children with Acute Lymphocytic Leukemia
Keywords: زنده ماندن بدون عود; ALL; Acute lymphocytic leukemia; BMI; Body mass index; BMI%; Body mass index percentile; BMT; Bone marrow transplantation; MH; Mild hyperglycemia; OH; Overt hyperglycemia; OS; Overall survival; RFS; Relapse-free survival;
Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study
Keywords: زنده ماندن بدون عود; Bladder carcinoma; ARCON; Late adverse events; Disease-specific survival; Relapse-free survival;
Blood counts at time of complete remission provide additional independent prognostic information in acute myeloid leukemia
Keywords: زنده ماندن بدون عود; Acute myeloid leukemia; Blood counts; Complete remission; Relapse-free survival; Prognostication
Adult Acute Myeloid Leukemia
Keywords: زنده ماندن بدون عود; AHD; antecedent hematologic disorder; ALSG; Australian Leukemia Study Group; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; As2O3; arsenic trioxide; ATRA; all-trans retinoic acid; CALGB; Cancer and Leukemia Group B; CR; complete remission
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995
Keywords: زنده ماندن بدون عود; Prostate cancer; Radiotherapy; Relapse-free survival; Radiation dose;
Interleukin 12 Is Associated with Reduced Relapse without Increased Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
Keywords: زنده ماندن بدون عود; Interleukin 12; Allogeneic hematopoietic stem cell transplantation; Relapse-free survival; Graft-versus-host disease (GVHD);
Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia
Keywords: زنده ماندن بدون عود; Chronic myelomonocytic leukemia; Allogeneic transplantation; Relapse-free survival; Comorbid conditions;